http://www.marketwatch.com/story/medicago-successfully-completes-the-production-of-more-than-ten-million-doses-of-h1n1-vlp-influenza-vaccine-in-one-month-2012-07-24-718300
Posted by Rob LW
hVIVO is the new name of Retroscreen Virology! (from 15 April 2015). hVIVO is a rapidly growing UK life sciences company pioneering a technology platform which uses human challenge models of disease involving healthy volunteers to study new drugs and investigate disease in a safe, controlled, clinical environment. Our belief is that the best way to understand human disease is by studying it in humans, not laboratory models.
No comments:
Post a Comment